ISAC is deeply aware and appreciative of the massive efforts currently being undertaken by our Member Societies and global colleagues in fighting the SARS CoV-2 / COVID-19 pandemic.
The International Society of Antimicrobial Chemotherapy (ISAC) is a federation of affiliated Member Societies which aims to increase the knowledge of antimicrobial chemotherapy and combat antibiotic resistance around the world.
Creating sustainable meta-competence in the prevention, diagnosis and treatment of infectious diseases and control of antimicrobial resistance in order to improve global health.
ISAC encourages National and Regional Professional Societies active in antimicrobial chemotherapy, clinical microbiology and infectious diseases to affiliate.
Our 25 Working Groups on specialist subjects are engaged in advancing scientific knowledge in antimicrobial chemotherapy, clinical microbiology and infectious diseases through various activities.
The Alliance for the Prudent Use of Antibiotics (APUA) has merged with ISAC.
ISAC is now offering small Project Grants exclusively to applicants from ISAC Member Societies.
Giuseppe Cornaglia and Jacques F. Acar will be greatly missed.
Please read ISAC's update on COVID-19.
All of us at ISAC were deeply saddened to learn of the recent passings of Giuseppe Cornaglia and Jacques F. Acar.
The abstracts from 31st ICC - 4th GCCMID 2019 are now available online!
As of January 2020, the Journal of Global Antimicrobial Chemotherapy (JGAR) is a fully open access journal with no subscription charges!
The latest newsletter from the Alliance for the Prudent Use of Antibiotics (APUA) is now online!
The 32nd International Congress of Antimicrobial Chemotherapy (ICC) will be held in partnership with the Australian Society for Antimicrobials in Perth, Australia from 21 - 24 November 2021.
Sign up for the latest news and events straight to your inbox